Compare Two Stocks
Valuation, growth, earnings reaction and guidance credibility, side by sideCVSCVS Health
FinDog View：Bullish
UNHUnitedHealth Group
FinDog View：Neutral
| Metric | CVS | UNH |
|---|
| Close | 91.72 | 375.26 |
| Market Cap | $117B | $337B |
| 1M | −2.44% | −5.15% |
| P/E (TTM) | 24.4 | 23.9 |
| Forward P/E | 13.2 | 19.7 |
| P/E 5-Yr Percentile | 65 | 53 |
| P/S | 0.3 | 0.8 |
| P/B | 1.5 | 3.2 |
| Dividend Yield | 3.49% | 1.37% |
| Latest Quarter Revenue | $106B | $112B |
| Revenue YoY | +7.3% | +0.4% |
| Gross Margin | 44.5% | 88.1% |
| Latest Quarter EPS | 2.31 | 6.04 |
| Avg Post-Earnings Move | ±2.3% | ±3.1% |
| EPS Beat Rate | — | — |
| Guidance Hit Rate | — | — |
| Shareholder Yield | 2.91% | 2.89% |
| 90-Day Net Insider Buying | — | −$0.66M |
CVS · Revenue, Last 8 Quarters ($B)
UNH · Revenue, Last 8 Quarters ($B)
